Session » SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster I

10:30AM-12:30PM

Abstract Number: 0574

14-3-3 Eta (η) Auto-Antibody as a Diagnostic Marker in Axial Spondyloarthritis: A Longitudinal Study

10:30AM-12:30PM

Abstract Number: 0544

A Two-year Comparison of Spinal and Hip Mobility Between Axial Spondyloarthritis and Chronic Back Pain Patients in the SPondyloArthritis Caught Early (SPACE) Cohort

10:30AM-12:30PM

Abstract Number: 0567

Alteration of JAK-STAT Signaling in an Axial Spondyloarthritispatient with TYK2 Variants

10:30AM-12:30PM

Abstract Number: 0577

AMH Titers in Women with Axial Spondyloarthritis Are Significantly Lower Compared to the General Population: An Analysis of the 10-year Follow-up of the DESIR Cohort

10:30AM-12:30PM

Abstract Number: 0553

Analyzing the Utilization of HLA-B27 Testing in a Large Rural Health System: Implications for Diagnostic Appropriateness

10:30AM-12:30PM

Abstract Number: 0560

Association Between a Self-Report Screening Tool for Sarcopenia (SARC-F) and Disease Activity, Muscle Strength and Muscle Power Measures, Patient-Reported Outcomes and Body Composition in Patients with Spondyloarthritides

10:30AM-12:30PM

Abstract Number: 0579

Association of the Presence of Active Acute Anterior Uveitis with Disease Activity in Axial Spondyloarthritis

10:30AM-12:30PM

Abstract Number: 0548

Associations and Impact of Kinesiophobia on Patient Reported Outcomes and Performance-based Mobility Measures in Patients with Axial Spondyloarthritis

10:30AM-12:30PM

Abstract Number: 0561

Axial Spondyloarthritis Patients with Comorbid Fibromyalgia Feel Worse, Work Less and More Often Try Multiple Biological DMARDs − Results from a Population-Based Cohort

10:30AM-12:30PM

Abstract Number: 0573

Characteristics of Difficult-to-Treat Ankylosing Spondylitis- Results from Real-World Data

10:30AM-12:30PM

Abstract Number: 0539

Clinical Expression of Radiographic Axial Spondyloarthritis and Its Association with HLA-B27 in European and Ibero-American Populations: Data from the REGISPONSER and RESPONDIA Registries

10:30AM-12:30PM

Abstract Number: 0563

Clinical Features of Patients with SpA, with or Without IBD: Results from the METEOR Cohort

10:30AM-12:30PM

Abstract Number: 0568

Coexistence of Raynaud’s Phenomenon, Morphea or Scleroderma in Spondyloarthritis Patients: Insights from a Retrospective Cohort Study Highlighting a Unique Phenotype

10:30AM-12:30PM

Abstract Number: 0575

Combined Testing of anti-CD74 IgA and Anti-UH-axSpA Antibodies Increases the Diagnostic Potential for axSpA

10:30AM-12:30PM

Abstract Number: 0554

Different Prevalence of Intestinal Inflammation in Radiographic and Non-radiographic Axial Spondyloarthritis. Data from EISER Study

10:30AM-12:30PM

Abstract Number: 0556

Disease Duration, Age and Clinical Features Related to Aortic Valve Sclerosis in Patients with Spondyloarthritis

10:30AM-12:30PM

Abstract Number: 0547

EspANDE Project: Improvement of Primary Care-Rheumatology Coordination in Spondyloarthritis in a Health Area in Northern Spain

10:30AM-12:30PM

Abstract Number: 0551

Evaluation of Instruments Assessing Peripheral Arthritis in Spondyloarthritis: An Analysis of the ASAS-perSpA Study

10:30AM-12:30PM

Abstract Number: 0578

Gender Differences in Disease Parameters, Adherence to Treat to Target Strategy and Outcomes in Axial Spondyloarthritis (axSpA) in Pakistani Cohort

10:30AM-12:30PM

Abstract Number: 0571

Gender-specific Performance of Disease Activity Assessment Tools in Axial Spondyloarthritis: Ancillary Analysis of the PREDICT-SpA Study

10:30AM-12:30PM

Abstract Number: 0549

Global Distribution and Determinants of Diagnostic Delay Across Diverse Spondyloarthritis Entities: Data from the International ASAS-Perspa Study

10:30AM-12:30PM

Abstract Number: 0546

Hiding in Plain Sight: The Impact of Implementing an Automated Inflammatory Back Pain Screening Tool on the Identification of Axial Spondyloarthritis in a Community Rheumatology Practice

10:30AM-12:30PM

Abstract Number: 0566

How Early Is Early? Unveiling Time to Diagnosis Since Symptom Onset and Its Determinants in Patients Suspected of Early Axial Spondyloarthritis: Data from the SPondyloArthritis Caught Early (SPACE) Cohort

10:30AM-12:30PM

Abstract Number: 0542

Impact of Peripheral Arthritis on Disease Activity Outcomes in Patients with Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis. Data from the ASAS-PerSpA Study

10:30AM-12:30PM

Abstract Number: 0543

Impact of Peripheral Manifestations on Function, Health, and Work Productivity in Patients with Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis. Data from the ASAS-PerSpA Study

10:30AM-12:30PM

Abstract Number: 0550

Is the Diagnostic Delay Getting Shorter with Time for Patients with Spondyloarthritis? Data from the International ASAS-PerSpA Study

10:30AM-12:30PM

Abstract Number: 0576

Less Than 15% Unfavourable Pregnancy Outcomes in Patients with Recent-onset Axial Spondyloarthritis: The Analysis of the 10 Years DESIR Cohort Follow-up

10:30AM-12:30PM

Abstract Number: 0565

Low Vitamin D Serum Level Is a Risk Factor for Ankylosis in Axial Spondyloarthritis: Evidence from a Nested-Case-Control Study

10:30AM-12:30PM

Abstract Number: 0541

Measurement Properties of Disease Activity Instruments in Peripheral Spondyloarthritis. an Analysis in the CRESPA Trial

10:30AM-12:30PM

Abstract Number: 0545

Missing Data in Observational Studies: Investigating Cross-sectional Single Imputation Methods for Assessing Disease Activity in Axial Spondyloarthritis

10:30AM-12:30PM

Abstract Number: 0540

Nonsteroidal Anti-Inflammatory Drug Use and Incident Hypertension Among Patients with Axial Spondyloarthritis

10:30AM-12:30PM

Abstract Number: 0558

Patient Diagnostic Journey and Time to Diagnosis in Axial Spondyloarthritis: A Retrospective Cohort Study Using US Claims Data

10:30AM-12:30PM

Abstract Number: 0559

Predicting Disease Flares in Axial Spondyloarthritis Using Machine Learning in the METEOR-SpA Registry

10:30AM-12:30PM

Abstract Number: 0552

Presence of MAIT Cells in Synovial Tissue of Patients with Axial Spondyloarthritis: A Comparative Study

10:30AM-12:30PM

Abstract Number: 0570

Prevalence of Comorbidities and Racial Disparities in Anterior Uveitis Risk Among Ankylosing Spondylitis Patients

10:30AM-12:30PM

Abstract Number: 0562

Serum Interleukin IL-40 as a Potential Biomarker Associated with Pro-inflammatory Activity in Inflammatory Bowel Diseases and Spondyloarthritis: A Preliminary Study

10:30AM-12:30PM

Abstract Number: 0572

Synergistic Impact of the Non-radiographic Axial Spondyloarthritis Subtype and Female Sex on First-Line Biologic Discontinuation : A Study of Interaction Effects

10:30AM-12:30PM

Abstract Number: 0555

The Effect of Alcohol Consumption on Clinical Outcomes and Structural Damage in Patients with Axial Spondyloarthritis: A Systematic Literature Review and Meta-Analysis

10:30AM-12:30PM

Abstract Number: 0569

The Longitudinal Association Between Disease Activity, Function and Health-Related Quality of Life in Axial Spondyloarthritis: Results from the DESIR Cohort

10:30AM-12:30PM

Abstract Number: 0564

The Risk of Venous Thromboembolism in Axial Spondyloarthritis: A Population-based Study

10:30AM-12:30PM

Abstract Number: 0557

What Factors Are Associated with Pain Intensity in Axial Spondyloarthritis? Results from the International Map of Axial Spondyloarthritis (IMAS)